Skip to Main Content

Author Details

Daniel J Ma
Mayo Clinic
2005
92
22
PMIDPaper TitleJournal TitlePublished Year
36222355Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity-modulated radiotherapy.Head Neck2023
35851669Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.Laryngoscope2023
37152485Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.Adv Radiat Oncol2023
37311338Clinical aspects of spatially fractionated radiation therapy treatments.Phys Med2023
37179098In Reply to Yigit et al.Int J Radiat Oncol Biol Phys2023
3660336430-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).Oral Oncol2023
36599392Close Margins After Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Carcinoma: A Review of the Literature and Practical Recommendations.Pract Radiat Oncol2023
36939471Impact of Tumor-Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus-Related Oropharyngeal Carcinoma.Otolaryngol Head Neck Surg2023
36309077A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.Int J Radiat Oncol Biol Phys2023
34236086Second Primary Tumors in Patients Presenting With Unilateral HPV-Associated Tonsillar Squamous Cell Carcinoma.Laryngoscope2022
35499087Manifestations of radiation toxicity in the head, neck, and spine: An image-based review.Neuroradiol J2022
35569469A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021.Int J Radiat Oncol Biol Phys2022
35814859The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal Cancer.Adv Radiat Oncol2022
35417782A Dosimetric Comparison of Lattice, Brass, and Proton Grid Therapy Treatment Plans.Pract Radiat Oncol2022
36129387Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer.Head Neck2022
36294304Evaluation of a New, Highly Flexible Radiofrequency Coil for MR Simulation of Patients Undergoing External Beam Radiation Therapy.J Clin Med2022
35101198In Regard to Soyfer et al.Int J Radiat Oncol Biol Phys2022
34859516An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.Head Neck2022
35076706Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.JAMA Netw Open2022
34509079The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective review.Am J Otolaryngol2022
34715395Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy.Pract Radiat Oncol2022
32969095Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.Head Neck2021
33741644<sup>18</sup>F-FDG-Avid Axillary Lymph Nodes After COVID-19 Vaccination.J Nucl Med2021
33516431Immunotherapy in Head and Neck Cancer-Ready for Prime Time or More Research Needed?Int J Radiat Oncol Biol Phys2021
33644935Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone.Head Neck2021
33864283Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294.Med Phys2021
33752487Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer.Otolaryngol Head Neck Surg2021
34814068Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancer.Oral Oncol2021
34455988Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm.Semin Radiat Oncol2021
34348102Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck.Int J Radiat Oncol Biol Phys2021
34285955Oncologic Outcomes for Head and Neck Skin Malignancies Treated with Protons.Int J Part Ther2021
34285957Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer.Int J Part Ther2021
34285949Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer.Int J Part Ther2021
34285942A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.Int J Part Ther2021
33429428Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.J Natl Cancer Inst2021
33359567Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.Int J Radiat Oncol Biol Phys2021
33130318VMAT Grid Therapy: A Widely Applicable Planning Approach.Pract Radiat Oncol2021
32663054Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.Otolaryngol Head Neck Surg2021
31433055Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.Neuro Oncol2020
32001382Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM).Int J Radiat Oncol Biol Phys2020
31852831Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.Clin Cancer Res2020
33094135The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers.Int J Part Ther2020
32712575T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma.Oral Oncol2020
32504888The prognostic role of medical comorbidities in surgically treated human papillomavirus-associated oropharyngeal squamous cell carcinoma.Oral Oncol2020
32277921Empowering Residents into Independent Practice: A Single-Institutional Endeavor Aimed at Developing Resident Autonomy Through Implementation of a Chief Resident Service in Radiation Oncology.Int J Radiat Oncol Biol Phys2020
32234612Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.Radiother Oncol2020
32426556Follow-Up and Management of Patients With Head and Neck Cancer During the 2019 Novel Coronavirus (SARS-CoV-2) Disease Pandemic.Adv Radiat Oncol2020
30395904Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.Int J Radiat Oncol Biol Phys2019
31557088Reply to A.S. Garden.J Clin Oncol2019
31206338Identifying the Most Costly Patients in Radiation Oncology and Predicting the Top Spenders.J Oncol Pract2019
  • 1 - 50 of 92

Recommended Authors

University of California San Francisco
Career Start Year 2017
Number of shared co-authors 4
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2017
Number of shared co-authors 4
University of California San Francisco
Career Start Year 2016
Number of shared co-authors 2
Princess Margaret Cancer Center
Career Start Year 2015
Number of shared co-authors 4
Stanford University
Career Start Year 2014
Number of shared co-authors 7
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 2
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 2
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 4
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 11
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 8
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 6
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 7
Center for Proton Therapy, Paul Scherrer Institute
Career Start Year 2000
Number of shared co-authors 1
Maastricht University Medical Centre
Career Start Year 1999
Number of shared co-authors 7
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 3
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 6
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 2
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 9
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 5
Radboud University Medical Center
Career Start Year 1987
Number of shared co-authors 4
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 4
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 15

Collaborators

Mayo Clinic
Co-authored papers 40
2Mayo Clinic
Co-authored papers 28
Mayo Clinic
Co-authored papers 23
Mayo Clinic
Co-authored papers 15
Co-authored papers 7
Mayo Clinic
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
National Cancer Centre Singapore
Co-authored papers 4
University of California san francisco
Co-authored papers 2
Mayo Clinic, Center for the Science of Health Care Delivery
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Duke University Medical Center
Co-authored papers 2
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Co-authored papers 2
Stanford University
Co-authored papers 2
Memorial Sloan-Kettering Cancer Center
Co-authored papers 1
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 1
Massachusetts Institute of Technology
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Inova Health System
Co-authored papers 1
Kasturba Medical College, Manipal Academy of Higher Education (MAHE)
Co-authored papers 1
Co-authored papers 1
Columbia University
Co-authored papers 1
Mayo Clinic School of Medicine, Mayo Clinic
Co-authored papers 1
University of Toronto
Co-authored papers 1
Mayo Clinic
Co-authored papers 1